SARS-CoV-2 B.1.617 Indian variants : Are electrostatic potential changes responsible for a higher transmission rate?
© 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC..
Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters δ and κ, is a recently described SARS-CoV-2 variant under investigation first identified in October 2020 in India. As of May 2021, three sublineages labeled as B.1.617.1 (κ), B.1.617.2 (δ), and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particular concern: E484Q, L452R, and P681R. Here, we report a major effect of the mutations characterizing this lineage, represented by a marked alteration of the surface electrostatic potential (EP) of the receptor-binding domain (RBD) of the spike protein. Enhanced RBD-EP is particularly noticeable in the B.1.617.2 (δ) sublineage, which shows multiple replacements of neutral or negatively charged amino acids with positively charged amino acids. We here hypothesize that this EP change can favor the interaction between the B.1.617+ RBD and the negatively charged ACE2, thus conferring a potential increase in the virus transmission.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
Journal of medical virology - 93(2021), 12 vom: 01. Dez., Seite 6551-6556 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pascarella, Stefano [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
B.1.617 δ and κ variants |
|---|
| Anmerkungen: |
Date Completed 27.10.2021 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/jmv.27210 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328056820 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328056820 | ||
| 003 | DE-627 | ||
| 005 | 20231225202136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.27210 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1093.xml |
| 035 | |a (DE-627)NLM328056820 | ||
| 035 | |a (NLM)34260088 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pascarella, Stefano |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 B.1.617 Indian variants |b Are electrostatic potential changes responsible for a higher transmission rate? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.10.2021 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC. | ||
| 520 | |a Lineage B.1.617+, also known as G/452R.V3 and now denoted by WHO with the Greek letters δ and κ, is a recently described SARS-CoV-2 variant under investigation first identified in October 2020 in India. As of May 2021, three sublineages labeled as B.1.617.1 (κ), B.1.617.2 (δ), and B.1.617.3 have been already identified, and their potential impact on the current pandemic is being studied. This variant has 13 amino acid changes, three in its spike protein, which are currently of particular concern: E484Q, L452R, and P681R. Here, we report a major effect of the mutations characterizing this lineage, represented by a marked alteration of the surface electrostatic potential (EP) of the receptor-binding domain (RBD) of the spike protein. Enhanced RBD-EP is particularly noticeable in the B.1.617.2 (δ) sublineage, which shows multiple replacements of neutral or negatively charged amino acids with positively charged amino acids. We here hypothesize that this EP change can favor the interaction between the B.1.617+ RBD and the negatively charged ACE2, thus conferring a potential increase in the virus transmission | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a B.1.617 δ and κ variants | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a electrostatics potential changes | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 700 | 1 | |a Ciccozzi, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Zella, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Bianchi, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Benedetti, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Benvenuto, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Broccolo, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Cauda, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Caruso, Arnaldo |e verfasserin |4 aut | |
| 700 | 1 | |a Angeletti, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Giovanetti, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Cassone, Antonio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 93(2021), 12 vom: 01. Dez., Seite 6551-6556 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2021 |g number:12 |g day:01 |g month:12 |g pages:6551-6556 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.27210 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 93 |j 2021 |e 12 |b 01 |c 12 |h 6551-6556 | ||